Opus Genetics Inc (NASDAQ: IRD) kicked off on Monday, up 9.60% from the previous trading day, before settling in for the closing price of $0.99. Over the past 52 weeks, IRD has traded in a range of $0.65-$2.18.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
While this was happening, its average annual earnings per share was recorded 60.62%. With a float of $39.42 million, this company’s outstanding shares have now reached $45.48 million.
Let’s look at the performance matrix of the company that is accounted for 18 employees. In terms of profitability, gross margin is 99.91%, operating margin of -564.72%, and the pretax margin is -523.4%.
Opus Genetics Inc (IRD) Insider Updates
Our next focus will be how large-scale investors are participating in this stock of the Biotechnology Industry. The insider ownership of Opus Genetics Inc is 33.93%, while institutional ownership is 22.78%. The most recent insider transaction that took place on Dec 26 ’24, was worth 97,600. In this transaction Chief Executive Officer of this company bought 100,000 shares at a rate of $0.98, taking the stock ownership to the 599,150 shares. Before that another transaction happened on Nov 21 ’24, when Company’s President bought 10,000 for $0.98, making the entire transaction worth $9,834. This insider now owns 342,800 shares in total.
Opus Genetics Inc (IRD) Performance Highlights and Predictions
According to the Wall Street analysts, stocks earnings will be around 60.62% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 35.76% during the next five years compared to 24.32% growth over the previous five years of trading.
Opus Genetics Inc (NASDAQ: IRD) Trading Performance Indicators
Take a look at Opus Genetics Inc’s (IRD) current performance indicators. Last quarter, stock had a quick ratio of 1.98. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 4.76.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -1.94, a number that is poised to hit -0.19 in the next quarter and is forecasted to reach -0.53 in one year’s time.
Technical Analysis of Opus Genetics Inc (IRD)
Opus Genetics Inc (NASDAQ: IRD) saw its 5-day average volume 8.16 million, a positive change from its year-to-date volume of 0.58 million. As of the previous 9 days, the stock’s Stochastic %D was 29.28%. Additionally, its Average True Range was 0.12.
During the past 100 days, Opus Genetics Inc’s (IRD) raw stochastic average was set at 40.00%, which indicates a significant increase from 19.81% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 49.52% in the past 14 days, which was lower than the 78.16% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $0.9286, while its 200-day Moving Average is $1.1097. Nevertheless, the first resistance level for the watch stands at $1.5433 in the near term. At $1.9967, the stock is likely to face the second major resistance level. The third major resistance level sits at $2.2433. If the price goes on to break the first support level at $0.8433, it is likely to go to the next support level at $0.5967. Assuming the price breaks the second support level, the third support level stands at $0.1433.
Opus Genetics Inc (NASDAQ: IRD) Key Stats
The company with the Market Capitalisation of 65.03 million has total of 59,661K Shares Outstanding. Its annual sales at the moment are 10,990 K in contrast with the sum of -57,530 K annual income. Company’s last quarter sales were recorded 4,370 K and last quarter income was -8,190 K.
